BHRT pellets vs creams vs patches: which is best and who offers them?

Short answer There is no one “best” BHRT delivery method for everyone. Choice depends on your treatment goals, how reliably you want steady blood levels, how easily you want doses changed, side‑effect tolerance and whether you want FDA‑approved products or compounded “bioidentical” preparations.

Comparison — pros / cons

• Pellets (subcutaneous implants)

  • Pros: very steady, long‑acting (typically 3–6 months), low daily compliance burden.
  • Cons: require a minor office procedure to insert and remove; dosing is hard to change quickly if symptoms or labs aren’t right; most pellets are compounded (not FDA‑approved), so quality can vary; risks include infection, extrusion, and unpredictable absorption in some people.
  • Who offers them: BioTE Medical (large U.S. network of BioTE‑trained clinicians), SottoPelle (international pellet clinic network) and many private anti‑aging/BHRT clinics that use compounded pellets. Look for board‑certified clinicians trained in pellet insertion and an experienced clinic.

• Creams / gels / topical preparations

  • Pros: easy to apply, can be titrated frequently, commonly used for local (vaginal) symptoms or for systemic delivery when compounded or with prescription gels. Good option if you want to adjust dose often.
  • Cons: skin absorption is highly variable (depends on formulation, site of application, skin condition), so blood levels can be unpredictable; compounded creams are not FDA‑regulated; risk of transfer to others (especially with testosterone creams).
  • Common products/providers: prescription estradiol cream (Estrace cream) or marketed topical gels like EstroGel (systemic estradiol gel) or Evamist (transdermal spray). For compounded BHRT creams use reputable compounding pharmacies (examples: Empower Pharmacy, Fagron, Wedgewood—ask your clinician which local USP‑compliant pharmacy they use).

• Patches

  • Pros: provide steady, predictable systemic dosing with FDA‑approved options; dosing is standardized and usually easier to monitor than creams; fewer first‑pass liver effects than oral estrogen.
  • Cons: can cause local skin irritation, patches can fall off, and progesterone delivery by patch is uncommon (oral micronized progesterone or levonorgestrel IUD often used instead).
  • Common brands: Vivelle‑Dot (estradiol patch), Climara (estradiol patch). For testosterone patches in men there is Androderm (less commonly used in women).

General guidance — which to pick

• If you want the most predictable, FDA‑standardized systemic dosing with easy monitoring: patches (or oral estradiol in some situations) are a good first choice.
• If you want a “set and forget” long‑interval option and accept less flexibility in dose adjustments: pellets can be attractive, but choose an experienced clinic and be prepared for the risks and variability.
• If you need local vaginal symptom relief (vaginal dryness, local atrophy): vaginal estrogen products (vaginal tablets like Vagifem, vaginal estradiol cream Estrace, or local rings) are usually best and use much lower systemic doses.
• If you prefer to fine‑tune doses frequently (or need combinations not available as standard products): compounded creams/gels are an option — but use a reputable compounding pharmacy and close medical supervision.

Who offers them (how to find a provider)

• Board‑certified OB/GYNs, family physicians and endocrinologists commonly manage menopausal BHRT and prescribe patches/gels and oral hormones.
• Pellets: search BioTE Medical clinic locator or SottoPelle clinic locator if you are specifically interested in pellet therapy; ask about provider training and infection/adverse‑event rates.
• Compounded creams/pellets: many private BHRT clinics and compounding pharmacies supply these—ask the clinic which USP‑compliant pharmacy they use (examples of large compounding pharmacies include Empower Pharmacy, Fagron, Wedgewood).
• For standardized products (patches, marketed gels, oral progesterone): any clinician who prescribes HRT (OB/GYN, primary care, endocrinologist) can prescribe them.

Safety and monitoring (important)

• Discuss risks with a clinician: systemic estrogen has risks (venous thromboembolism, stroke, possible breast cancer concerns depending on regimen and personal history) and needs individual risk/benefit assessment.
• Baseline evaluation: medical history, breast/cardiovascular risk assessment and baseline labs as indicated (hormone levels, lipids, liver function and others per your clinician).
• Follow‑up: symptom review and lab monitoring as needed; patches and gels make dosage adjustments easier than pellets.

If you’d like, tell me:

• Are you asking for menopausal symptom relief, low libido, transgender care, or another indication?
• Any medical history (blood clots, breast cancer, liver disease) that affects safety?

I can then suggest the most appropriate delivery option and help you find a nearby clinician or reputable clinics (BioTE, SottoPelle) or FDA‑approved products (Vivelle‑Dot, Climara, Estrace, Prometrium for oral progesterone).